MediciNova Inc
NASDAQ:MNOV
MediciNova Inc
NASDAQ:MNOV
Price:
1.36 USD
2.26%
Market Closed
Updated:
Jun 2, 2024
MediciNova Inc
Total Liabilities
|
MediciNova Inc
Total Liabilities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
MediciNova Inc
NASDAQ:MNOV
|
Total Liabilities
$3.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$140.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$38.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$88B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$5.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities
$7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
See Also
What is MediciNova Inc's Total Liabilities?
Total Liabilities
3.9m
USD
3.9m
USD
Based on the financial report for Dec 31, 2023, MediciNova Inc's Total Liabilities amounts to 3.9m USD.
What is MediciNova Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
-1%
-1%
Over the last year, the Total Liabilities growth was 0%. The average annual Total Liabilities growth rates for MediciNova Inc have been -2% over the past three years , -1% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
